NCT03621865View on ClinicalTrials.gov

A Comparative Pharmacokinetic Study to Evaluate the Ability of a New Formulation to Enhance Curcuminoids Bioavailability

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 26, 2018

Primary Completion Date

October 26, 2018

Study Completion Date

October 26, 2018

Conditions
Healthy
Interventions
DIETARY_SUPPLEMENT

TG

Turmipure GOLD™ 30% curcuminoids (300 mg)

DIETARY_SUPPLEMENT

STE

Standard turmeric powder extract 95% curcuminoids (1500 mg)

DIETARY_SUPPLEMENT

NOV

Novasol® Liquid micellar formulation 6% curcuminoids (1000 mg)

DIETARY_SUPPLEMENT

PHYT

Meriva® Turmeric Phytosome formulation 20% curcuminoids (1000 mg)

DIETARY_SUPPLEMENT

TEP

Turmeric extract C3 complex® 95% curcuminoids (1500mg) + BioPerine® 95% piperine (15 mg)

Trial Locations (1)

44800

Biofortis Mérieux NutriSciences, Saint-Herblain

All Listed Sponsors
collaborator

Biofortis Mérieux NutriSciences

OTHER

lead

Givaudan France Naturals

INDUSTRY

NCT03621865 - A Comparative Pharmacokinetic Study to Evaluate the Ability of a New Formulation to Enhance Curcuminoids Bioavailability | Biotech Hunter | Biotech Hunter